Uniqure NVNASDAQ:QURE
- LAST PRICE4.5600
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots4.4100/ 1
- Ask / Lots4.6500/ 97
- Open / Previous Close0.0000 / 4.5600
- Day Range---
- 52 Week Range
- Volume169
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | QURE |
|---|---|---|
| 09:32 ET | 1750 | 4.77 |
| 09:36 ET | 200 | 4.77 |
| 09:38 ET | 800 | 4.76 |
| 09:39 ET | 3534 | 4.735 |
| 09:41 ET | 1890 | 4.715 |
| 09:43 ET | 1253 | 4.73 |
| 09:45 ET | 300 | 4.72 |
| 09:48 ET | 1900 | 4.72 |
| 09:50 ET | 418 | 4.72 |
| 09:52 ET | 300 | 4.73 |
| 09:56 ET | 400 | 4.72 |
| 09:57 ET | 1000 | 4.714 |
| 10:01 ET | 8937 | 4.695 |
| 10:03 ET | 2200 | 4.69 |
| 10:06 ET | 200 | 4.695 |
| 10:08 ET | 4463 | 4.715 |
| 10:10 ET | 784 | 4.71 |
| 10:12 ET | 464 | 4.71 |
| 10:14 ET | 15098 | 4.72 |
| 10:15 ET | 5703 | 4.72 |
| 10:17 ET | 400 | 4.72 |
| 10:21 ET | 100 | 4.7275 |
| 10:24 ET | 400 | 4.725 |
| 10:26 ET | 200 | 4.72 |
| 10:28 ET | 2666 | 4.725 |
| 10:30 ET | 200 | 4.725 |
| 10:33 ET | 1337 | 4.715 |
| 10:35 ET | 3279 | 4.715 |
| 10:37 ET | 1000 | 4.715 |
| 10:39 ET | 800 | 4.715 |
| 10:42 ET | 30971 | 4.715 |
| 10:44 ET | 17565 | 4.705 |
| 10:46 ET | 400 | 4.715 |
| 10:48 ET | 2400 | 4.71 |
| 10:50 ET | 600 | 4.71 |
| 10:51 ET | 13899 | 4.685 |
| 10:53 ET | 9359 | 4.675 |
| 10:55 ET | 1700 | 4.66 |
| 11:00 ET | 1376 | 4.65 |
| 11:02 ET | 1388 | 4.6388 |
| 11:04 ET | 7541 | 4.615 |
| 11:06 ET | 430 | 4.6 |
| 11:08 ET | 328 | 4.5912 |
| 11:09 ET | 959 | 4.59 |
| 11:11 ET | 7488 | 4.625 |
| 11:13 ET | 1348 | 4.625 |
| 11:15 ET | 2000 | 4.6279 |
| 11:18 ET | 1066 | 4.63 |
| 11:20 ET | 600 | 4.63 |
| 11:22 ET | 3779 | 4.6324 |
| 11:24 ET | 100 | 4.63 |
| 11:26 ET | 300 | 4.635 |
| 11:27 ET | 100 | 4.635 |
| 11:29 ET | 400 | 4.635 |
| 11:31 ET | 300 | 4.625 |
| 11:36 ET | 2371 | 4.615 |
| 11:38 ET | 500 | 4.6199 |
| 11:40 ET | 200 | 4.61 |
| 11:42 ET | 872 | 4.605 |
| 11:44 ET | 600 | 4.605 |
| 11:45 ET | 1665 | 4.615 |
| 11:47 ET | 300 | 4.61 |
| 11:49 ET | 6804 | 4.59 |
| 11:51 ET | 700 | 4.585 |
| 11:54 ET | 1200 | 4.6 |
| 11:56 ET | 1000 | 4.59 |
| 11:58 ET | 6198 | 4.5942 |
| 12:00 ET | 100 | 4.592 |
| 12:02 ET | 800 | 4.585 |
| 12:03 ET | 500 | 4.59 |
| 12:05 ET | 300 | 4.585 |
| 12:07 ET | 611 | 4.5872 |
| 12:09 ET | 1400 | 4.58 |
| 12:12 ET | 1100 | 4.585 |
| 12:14 ET | 28432 | 4.615 |
| 12:16 ET | 400 | 4.61 |
| 12:20 ET | 800 | 4.6 |
| 12:21 ET | 100 | 4.595 |
| 12:23 ET | 300 | 4.585 |
| 12:27 ET | 625 | 4.5801 |
| 12:30 ET | 19730 | 4.5955 |
| 12:32 ET | 1584 | 4.585 |
| 12:34 ET | 300 | 4.585 |
| 12:36 ET | 200 | 4.585 |
| 12:38 ET | 300 | 4.585 |
| 12:39 ET | 1884 | 4.585 |
| 12:41 ET | 200 | 4.585 |
| 12:43 ET | 200 | 4.585 |
| 12:45 ET | 200 | 4.585 |
| 12:48 ET | 100 | 4.585 |
| 12:52 ET | 400 | 4.5899 |
| 12:54 ET | 300 | 4.585 |
| 12:56 ET | 400 | 4.585 |
| 12:57 ET | 3144 | 4.59 |
| 12:59 ET | 1500 | 4.58 |
| 01:01 ET | 100 | 4.59 |
| 01:03 ET | 309 | 4.585 |
| 01:08 ET | 19703 | 4.6 |
| 01:10 ET | 1527 | 4.59 |
| 01:14 ET | 200 | 4.585 |
| 01:15 ET | 300 | 4.585 |
| 01:17 ET | 105 | 4.585 |
| 01:19 ET | 900 | 4.585 |
| 01:21 ET | 500 | 4.585 |
| 01:24 ET | 200 | 4.585 |
| 01:26 ET | 100 | 4.585 |
| 01:28 ET | 200 | 4.585 |
| 01:30 ET | 200 | 4.585 |
| 01:33 ET | 3591 | 4.59 |
| 01:35 ET | 1054 | 4.59 |
| 01:44 ET | 103 | 4.585 |
| 01:46 ET | 1600 | 4.585 |
| 01:50 ET | 1000 | 4.588 |
| 01:51 ET | 200 | 4.585 |
| 01:53 ET | 100 | 4.585 |
| 01:57 ET | 100 | 4.585 |
| 02:00 ET | 348 | 4.5899 |
| 02:02 ET | 100 | 4.585 |
| 02:04 ET | 3627 | 4.588 |
| 02:06 ET | 700 | 4.585 |
| 02:08 ET | 800 | 4.58 |
| 02:09 ET | 300 | 4.5875 |
| 02:11 ET | 2400 | 4.565 |
| 02:13 ET | 2240 | 4.54 |
| 02:15 ET | 7521 | 4.54 |
| 02:18 ET | 595 | 4.54 |
| 02:20 ET | 100 | 4.545 |
| 02:24 ET | 1314 | 4.5201 |
| 02:26 ET | 1800 | 4.52 |
| 02:29 ET | 680 | 4.519 |
| 02:31 ET | 1505 | 4.52 |
| 02:33 ET | 1550 | 4.5249 |
| 02:36 ET | 100 | 4.525 |
| 02:40 ET | 3715 | 4.53 |
| 02:44 ET | 2610 | 4.545 |
| 02:45 ET | 763 | 4.54 |
| 02:47 ET | 1500 | 4.545 |
| 02:49 ET | 10745 | 4.53 |
| 02:51 ET | 1328 | 4.525 |
| 02:54 ET | 300 | 4.515 |
| 02:56 ET | 3175 | 4.51 |
| 02:58 ET | 100 | 4.5 |
| 03:00 ET | 300 | 4.505 |
| 03:02 ET | 2465 | 4.5 |
| 03:03 ET | 300 | 4.49 |
| 03:05 ET | 400 | 4.495 |
| 03:07 ET | 2111 | 4.481 |
| 03:09 ET | 1507 | 4.495 |
| 03:14 ET | 12020 | 4.51 |
| 03:18 ET | 800 | 4.515 |
| 03:20 ET | 1880 | 4.5199 |
| 03:21 ET | 7656 | 4.545 |
| 03:23 ET | 300 | 4.545 |
| 03:25 ET | 1000 | 4.545 |
| 03:27 ET | 459 | 4.5375 |
| 03:32 ET | 3400 | 4.535 |
| 03:34 ET | 400 | 4.53 |
| 03:36 ET | 1700 | 4.545 |
| 03:38 ET | 2913 | 4.535 |
| 03:39 ET | 100 | 4.535 |
| 03:41 ET | 800 | 4.54 |
| 03:45 ET | 200 | 4.53 |
| 03:48 ET | 10639 | 4.535 |
| 03:50 ET | 2614 | 4.545 |
| 03:52 ET | 3640 | 4.54 |
| 03:54 ET | 33017 | 4.555 |
| 03:56 ET | 5556 | 4.555 |
| 03:57 ET | 5238 | 4.555 |
| 03:59 ET | 36489 | 4.56 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Uniqure NV | 218.1M | -0.7x | --- |
Lineage Cell Therapeutics Inc | 207.4M | -8.9x | --- |
AC Immune SA | 235.1M | -3.4x | --- |
CervoMed Inc | 214.1M | -39.2x | --- |
Fennec Pharmaceuticals Inc | 245.8M | -15.0x | --- |
Mediwound Ltd | 167.0M | -22.9x | --- |
Company Information
Uniqure NV is a company based in the Netherlands specialized in gene therapy. It seeks to develop one-time administered treatments with potentially curative results for patients suffering from genetic and other devastating diseases. It develops, both internally and through partnerships, a pipeline of gene therapies. It produces adeno-associated virus based, or AAV-based, gene therapies in its own facilities with a proprietary, commercial-scale, current good manufacturing practices, compliant, manufacturing process. AMT-061, the Company’s lead product candidate for patients with hemophilia B, is going through a dosing phase of a pivotal study. AMT-130, the product candidate for patients with Huntington’s disease is in Phase I/II clinical study.
Contact Information
- Headquarters
- Paasheuvelweg 25aAMSTERDAM, Netherlands 1105 BP
- Phone
- ---
- Fax
- ---
Executives
- Non-Executive Independent Chairman of the Board
- David Meek
- Chief Executive Officer, Executive Director
- Matthew Kapusta
- Chief Financial Officer
- Christian Klemt
- Chief Operations Officer
- Pierre Caloz
- Chief Business and Scientific Officer
- Ricardo Dolmetsch
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $218.1M |
|---|---|
Revenue (TTM) | $15.8M |
Shares Outstanding | 47.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.97 |
EPS | $-6.47 |
Book Value | $4.34 |
P/E Ratio | -0.7x |
Price/Sales (TTM) | 13.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,785.46% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
